RSS

molecular diagnostics

The ultra-rapid Point-Of-Care (POC) molecular diagnostics company, Atlas Genetics, has received a £2 million phase II contract from Innovate UK for the expansion of the STI test menu on its io rapid diagnostic platform. more

Technology

Biocartis Group, a molecular diagnostics company, has announced an extension of its partnership with ETPL with a new five-year strategic partnership, focused on the development of molecular diagnostic assays for Biocartis’ Idylla platform. more

News

Biocartis Group, a molecular diagnostics company, has established a US subsidiary, Biocartis US, and has appointed Vishal Sikri as its US general manager. more

News